Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Hospira, Inc. | McPherson, KS, United States | Makes it and tests it | Problems found, fixed voluntarilyJan 17, 2025 · 16 inspections, 2 with FDA action |
| Hovione Farmaciencia, S.a. | Loures, Portugal | Makes the active ingredient and tests it | Problems found, fixed voluntarilyOct 24, 2024 · 10 inspections |
| AndersonBrecon Inc. | Rockford, IL, United States | Packages it and labels it | No problems foundAug 19, 2026 · 11 inspections |
| Eurofins Lancaster Laboratories, LLC | Lancaster, PA, United States | Tests it | Problems found, fixed voluntarilyAug 26, 2025 · 8 inspections |
| North American Science Associates, LLC | Northwood, OH, United States | Tests it | No problems foundApr 26, 2024 · 5 inspections |
| Solvias AG | Kaiseraugst, Switzerland | Tests it | Problems found, fixed voluntarilyAug 7, 2025 · 10 inspections |
Product details
- Generic drug
- Plazomicin: every company that makes it
- Form
- injection, intravenous
- Strength
- 500 mg per 10 mL
- Approval
- NDA NDA210303
- On the market since
- Jul 16, 2018
- Package NDCs
80735-820-3780735-820-96- Official label
- DailyMed (National Library of Medicine), updated Feb 27, 2023
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?